Luminex Gets FDA Approval And CE Mark For SYNCT Software

Luminex Corporation LMNX disclosed the FDA has given its approval for its SYNCT software. Similarly, CE Marking has also given clearance for use with its ARIES system and NxTAG assays on the MAGPIX system.

Luminex said SYNCT software was nothing but a middleware offering access to data and reports through a single interface. The company added that it enables for customization of workflows by linking ARIES and NxTAG-powered MAGPIX workstations in the lab.

St. John Hospital and Medical Center's Medical Laboratory Scientist, Tong Her, commented, "SYNCT is efficient software for our daily workflow." The Scientist continued "The order management menu makes it easy to order tests and the 'run report' tool allows for simple interpretation of test results."

The company's VP of global marketing, Eric Shaprio, also said that "Challenges associated with software and information systems that don't talk to each other waste precious time that lab directors would rather spend maximizing efficiency and ensuring the most accurate and reproducible results from their lab". He added that "We are proud to offer our molecular lab customers a better way to manage their data while reducing operational costs."

On Wednesday, the stock closed at $19.99.